Clinical Trial Update: Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating HVA regimens as salvage therapy for refractory/relapsed acute myeloid leukemia and related erythroid leukemias; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Erythroid Leukemia

Drugs mentioned

• HVA regimen

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Refractory Acute Myeloid Leukemia, Relapsed Acute Erythroid Leukemia | Phase 2 | Status: COMPLETED